Search for: "Bristol-Myers Squibb U.S. Pharmaceutical Group"
Results 1 - 20
of 43
Sort by Relevance
|
Sort by Date
25 Jan 2023, 1:37 pm
The settlement listed in the hundred spot on the list is 2006 settlement of $185 million in the Bristol-Myers Squibb Co. case. [read post]
6 Jan 2023, 2:33 pm
Bristol-Myers Squibb paying $75 million to resolve allegations was the seventh largest Healthcare Fraud recovery on last year’s list. [read post]
25 Jun 2021, 4:15 am
A group of intellectual property professors; GlaxoSmithKline plc; and Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
2 Jan 2020, 11:23 am
The most recent is the 2017 Bristol-Myers Squibb v. [read post]
12 Sep 2019, 5:44 pm
Francis Rooney (R-FL) wrote a letter to the FTC, urging the agency to investigate Bristol-Myers Squibb Company’s (“Bristol-Myers”) acquisition of Celgene Corporation (“Celgene”). [read post]
15 Nov 2017, 8:00 am
Bristol-Myers Squibb v. [read post]
17 Jul 2017, 2:03 pm
To address these issues and concerns head on, the New Jersey Association of Biomedical Research recently hosted one of the most significant efforts to promote biomedical research advocacy, the “Biomedical Research Summit,” presented by Bristol-Myers Squibb, also sponsored by Covance, Charles River Laboratories, s-tune software, Inc., Marshall BioResources, and Allentown, Inc. [read post]
3 Jul 2017, 6:15 am
In Bristol-Myers Squibb Company v. [read post]
19 Jun 2017, 12:47 pm
Before we can even finish pondering that, Alito is on to his second case, Bristol-Myers Squibb Co. v. [read post]
26 Apr 2017, 1:35 pm
Tuesday morning’s argument in Bristol-Myers Squibb v. [read post]
4 Aug 2016, 9:24 am
It is Bristol-Myers Squibb’s top-selling drug; it earned the pharmaceutical company $6.4 billion in 2013. [read post]
6 May 2016, 12:30 pm
Tap Pharmaceuticals, Inc., 2004 WL 2550593, at *5 (W.D. [read post]
9 Jul 2015, 3:28 pm
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
19 Jun 2015, 6:30 am
Food and Drug Administration (FDA) approved the first AB-rated generics to Bristol-Myers Squibb and Otsuka’s Abilify® (aripiprazole) tablets, an atypical antipsychotic drug commonly used for treating schizophrenia and bipolar disorder. [read post]
25 Apr 2015, 11:03 am
In the course of identifying this second assumption, the Manual now points out that the doubling argument turns on applying “an average risk for the group” to each individual in the group. [read post]
24 Mar 2015, 11:54 am
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
26 Feb 2015, 5:00 am
Merrell-Dow Pharmaceuticals, Inc., 523 A.2d 374 (Pa. [read post]
13 Apr 2014, 8:59 am
Bristol-Myers Squibb Co. v. [read post]
15 Feb 2013, 9:29 am
Bristol-Myers Squibb Company v. [read post]
10 Sep 2012, 7:28 pm
Mich. 1996); Bristol-Myers Squibb Co. v. [read post]
